CoChat
Sign Up
Cited by 234Treatment of Major DepressionElectroconvulsive Therapy StudiesMental Health Treatment and Access

The DOI matches its Crossref record.

Prospective, Long-Term, Multicenter Study of the Naturalistic Outcomes of Patients With Treatment-Resistant Depression

Dunner, David L., Rush, A. John, Russell, James M., Burke, Michael, Woodard, Stacy, Wingard, Peggy, Allen, John·2006·The Journal of Clinical Psychiatry
DOI 10.4088/jcp.v67n0501
Open this paper in CoChat — free account

Abstract

BACKGROUND: Treatment-resistant depression (TRD) is a long-term, disabling illness. We report on the characteristics and outcomes of a large cohort of patients with a level of treatment resistance that is very substantial and who were treated for 2 years with standard care. METHOD: This 2-year prospective, multicenter, observational study (patients enrolled from January 2001 through July 2004) tracked the outcomes of 124 patients with treatment-resistant, nonpsychotic major depressive disorder (N = 109) or bipolar depressed phase disorder (N = 15) who received treatment as usual (TAU) (i.e., any therapeutic regimen agreed to by patients and psychiatrists, including medications, electroconvulsive therapy [ECT], and psychotherapy). Treatments could be adjusted, started, and stopped as necessary. The primary outcome, treatment response, was defined a priori as > or = 50% improvement from baseline as measured by the 30-item Inventory of Depressive Symptomatology-Self-Report (IDS-SR-30). Remission was defined as an IDS-SR-30 score of < or = 14. The Medical Outcomes Study (MOS) 36-item Short Form Health Survey (SF-36) was used to monitor quality-of-life changes. RESULTS: The 12- and 24-month IDS-SR-30 response rates were 11.6% (13/112) and 18.4% (19/103), respectively. Of the 13 responders at 12 months, only 5 were responders at 24 months. The 12- and 24-month IDS-SR-30 remission rates were 3.6% (4/112) and 7.8% (8/103), respectively. Only 1 of the 4 12-month remitters was also a remitter at 24 months. The SF-36 indicated globally poor quality of life in this sample. CONCLUSIONS: Despite the wide range of treatment options available for depression, the response rates, remission rates, and quality-of-life results in this study show that most patients with a substantial degree of treatment resistance continue to have significant symptomatology and functional disability when receiving TAU.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v67n0501

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

Sorted by citations

Items 201–233 of 233

Related

See all

Metadata

Authors
Dunner, D. L., Rush, A. J., Russell, J. M., Burke, M., Woodard, S., Wingard, P., & Allen, J.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Eli Lilly (United States) (US)
  • University of Kansas (US)
  • IQVIA (United States) (US)
ORCID
Venue
The Journal of Clinical Psychiatry
Publisher
Physicians Postgraduate Press, Inc
Published
2006-05-15
Volume
67
Issue
05
Pages
688-695
ISSN
0160-6689 (ISSN-L)
DOI
10.4088/jcp.v67n0501
OpenAlex
W1978161441
Cited by
234
References
0
Citations by year
2026: 10 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 23 · 2021: 11 · 2020: 13 · 2019: 14 · 2018: 22 · 2017: 11 · 2016: 10 · 2015: 6 · 2014: 10 · 2013: 9 · 2012: 13
FWCI
5.85
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
treatment-resistant depression, major depressive disorder, bipolar depression, treatment response, remission, quality of life, functional disability, long-term outcomes, usual care, electroconvulsive therapy, psychotherapy, antidepressant treatment
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Drug Resistance, Electroconvulsive Therapy, Health Status, Humans, Longitudinal Studies, Middle Aged, Personality Inventory, Prospective Studies, Psychiatric Status Rating Scales, Psychotherapy, Psychotropic Drugs, Quality of Life, Surveys and Questionnaires, Recurrence, Cohort Studies, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review